Rite Aid files for bankruptcy amid slowing sales, opioid litigation

Rite Aid files for bankruptcy: Rite Aid filed for Chapter 11 bankruptcy protection in New Jersey on Sunday and stated it would commence reorganisation efforts to substantially reduce its debt.

The company announced that it has achieved an agreement with its creditors on a restructuring plan that includes a review of its retail footprint and the closure of underperforming locations.

Additionally, Rite Aid announced that lenders have agreed to provide $3.45 billion in new funding to “provide sufficient liquidity” as the company implements its restructuring plan.

Rite Aid files for bankruptcy

The drugstore chain has been struggling with declining sales, rising debt, and a slew of litigation alleging that its oversupply of painkillers contributed to the nation’s opioid epidemic.

During its most recent quarter, which ended on June 3rd, revenue decreased from $6.01 billion to $5.65 billion. Its net loss increased to $306.7 million, or $5.56 per share, from $110.2 million, or $2.03 per share, during the same period one year prior.

As a consequence of the difficult quarter, Rite Aid lowered its outlook for fiscal 2024 and warned investors that it anticipates a loss of between $650 million and $680 million for the full year, which is scheduled to end in late February.

Rite Aid’s retail pharmacy segment has long been a key growth driver, but this has not been sufficient to counterbalance the company’s mounting losses.

A decline in demand for Covid vaccines and testing, a decline in the company’s prescription drug plan membership, and a loss of consumers from its Elixir pharmacy benefits business have contributed to a revenue slowdown at the struggling drug chain.

Jeffrey Stein was appointed as the company’s new chief executive officer, chief restructuring officer, and board member on Sunday. Elizabeth Burr served as interim CEO since January and will continue to serve on the board of directors.

Bruce Bodaken, chairman of Rite Aid, issued the following statement: “Jeff is a proven leader with a strong track record of guiding companies through financial restructurings. We anticipate gaining from his contributions and capitalising on his expertise as we strengthen Rite Aid’s foundation and position the company for long-term success.”

Stein stated that he has “extreme faith in this company and the turnaround strategy developed in recent months.”

Two Chinese banks get provisional OK to enter bankruptcy proceedings

A crisis of existence for drugstores

As shoppers increasingly turn to Amazon, Target, Walmart, and others for toothpaste, shampoo, and other necessities — often at a lower price and with door-to-door delivery — drugstores like Rite Aid have faced an existential crisis.

Rite Aid has also struggled to keep up with its larger competitors, CVS and Walgreens, who have shifted their focus to health care and made substantial investments to match.

CVS has opened in-store Minute Clinics, which resemble walk-in urgent care centres, and converted a growing number of its stores into HealthHubs, which offer a broader range of medical services.

It has expanded its presence in the health care industry by acquiring Caremark, one of the largest pharmacy benefits managers, health insurer Aetna, and most recently, primary-care provider Oak Street Health.

Walgreens has also entered into costly agreements to expand its presence in health care. It has acquired a majority stake in primary-care provider VillageMD and plans to open doctor offices adjacent to many of its pharmacies.

New and well-capitalized entrants into the health care industry have also heightened the competitive threat. Amazon completed the $3.9 billion acquisition of primary-care provider One Medical earlier this year and acquired online pharmacy PillPack in 2018. Walmart has established a growing network of medical clinics in various regions of the country.

The opioid epidemic

The numerous lawsuits Rite Aid faces allege that the company contributed to the nation’s opioid epidemic by knowingly filling prescriptions for painkillers that did not satisfy legal requirements.

In January of this year, the Department of Justice filed a lawsuit against Rite Aid, alleging that it violated the Controlled Substances Act by completing thousands of illegal prescriptions for controlled substances like fentanyl and oxycodone.

Rite Aid has urged a court to dismiss the department’s lawsuit and has denied any wrongdoing.